Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-01-10 @ 2:11 PM
Study NCT ID:
NCT00045903
Status:
COMPLETED
Last Update Posted:
2014-04-23
First Post:
2002-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
Sponsor:
New York State Psychiatric Institute
Organization:
Study Overview
Official Title:
CBT Augmentation for SRI Pharmacotherapy in OCD
Status:
COMPLETED
Status Verified Date:
2012-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Aug1
Brief Summary:
This study will evaluate the effectiveness of two cognitive behavioral therapies (CBTs) in treating obsessive compulsive disorder (OCD) in patients who are taking medication but still have residual symptoms.
Detailed Description:
Participants remain on their current OCD medication and are randomly assigned to receive one of two CBTs: exposure and ritual prevention or stress management therapy. Exposure and ritual prevention involves imaginal and in-vivo exposure and requires that participants refrain from ritualizing. Stress management involves relaxation, assertiveness training, and structured problem-solving. Therapy occurs twice per week for 2 months. Participants are assessed verbally by an independent evaluator and are asked to complete self-rating forms. Patients who respond are followed for up to 1 additional year. Participants continue to take the same medication and the same monthly therapy for the first 6 months of follow-up. During the second 6 months of follow-up, participants discontinue therapy but continue taking the same medication.
For information on a related study, please follow this link:
http://clinicaltrials.gov/show/NCT00389493
For information on a related study, please follow this link:
http://clinicaltrials.gov/show/NCT00389493
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R01MH045436-01 | NIH | None | https://reporter.nih.gov/quic… | View |
| DSIR AT-CT | None | None | View |